Enzon Pharmaceuticals Inc (ENZN.O)

ENZN.O on Consolidated Issue listed on NASDAQ Capital Market

1.03USD
19 Dec 2014
Price Change (% chg)

$-0.02 (-1.90%)
Prev Close
$1.05
Open
$1.07
Day's High
$1.07
Day's Low
$1.02
Volume
289,144
Avg. Vol
243,126
52-wk High
$1.83
52-wk Low
$0.78

ENZN.O

Chart for ENZN.O

About

Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company’s drug development programs utilize two platforms: Customized PEGylation Linker Technology (Customized Linker Technology) and third-generation messenger ribonucleic acid (mRNA) antagonists utilizing the Locked Nucleic Acid (LNA) technology. The Company... (more)
No analyst recommendations are available for ENZN.O.

Overall

Beta: 1.33
Market Cap (Mil.): $45.47
Shares Outstanding (Mil.): 44.14
Dividend: 0.10
Yield (%): --

Financials

  ENZN.O Industry Sector
P/E (TTM): 1.61 159.35 38.84
EPS (TTM): 0.64 -- --
ROI: 116.18 -0.82 18.26
ROE: 118.64 -1.98 19.12
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks